Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 691

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 691
---
, and is not expected to be deductible for income tax purposes. The final calculation of goodwill could differ materially from the preliminary amounts presented in this unaudited pro forma condensed combined financial information due to several factors including, but not limited to, changes in the estimated fair value of assets acquired and liabilities assumed, and differences in the actual assets acquired and liabilities assumed at the effective time of the Mergers, including the final calculation of Merger Consideration that is subject to further purchase price adjustments as described in the amended Merger Agreement. Goodwill will not be amortized, but instead will be tested for impairment at least annually or more frequently if certain indicators are present. In the event that the value of goodwill or other intangible assets have become impaired, an accounting charge for impairment during the period in which the determination is made may be recognized.FRelating to the Mergers, reflects the total estimated transaction costs of both TuHURA and Kineta already incurred and expected to be incurred to close the Mergers of $6,952,993, which is comprised of $4,353,000 of aggregate costs incurred by TuHURA and $2,599,993 incurred by Kineta.F1Kineta’s total estimated transaction costs of $2,599,993 include accounting advisory, legal, and special employee-related fees. Of this amount, $1,167,050 had already been incurred and included within Accounts payable and accrued expenses as of December 31, 2024, and therefore, $1,432,943 is expected to be incurred upon the Closing of the Mergers. Within this amount were additional expenses that have yet to be incurred and recognized related toone-timespecial bonus and severance costs of $971,988, as well as transaction costs related to professional and legal fees which are expected to be directly attributable to the transaction of $460,955, and therefore both were adjusted for within the accumulated deficit in the December 31, 2024 pro forma condensed combined balance sheet to give the pro forma effect from recording the transaction costs in general and administrative expenses during the twelve months ended December 31, 2024 as shown in the pro forma condensed combined statement of operations (refer to adjustmentEE(i)).Of the$2,599,993 total of Kineta’s estimated transaction costs,$1,600,993 is expected to be paid in cash as of the close of the Mergers and, as such, $999,000 of Kineta’s estimated transaction costs are expected to remain unpaid.